Intest Res.  2017 Oct;15(4):543-545. 10.5217/ir.2017.15.4.543.

Irritable bowel syndrome-like symptoms associated with endoscopic activity predict ulcerative colitis relapse in patients with clinical remission

• Fukuba N
• Ishihara S
• Kawashima
• Mishima Y
• Oshima N
• Kinoshita

• KMID: 2396407
• DOI: http://doi.org/10.5217/ir.2017.15.4.543

Abstract

No abstract available.

MeSH Terms

Colitis, Ulcerative*
Humans
Recurrence*
Ulcer*

Figure

• 

  Fig. 1 The relapse-free period of patients with UC in remission with IBS-like symptoms was shorter compared to that of patients with UC without IBS-like symptoms (P<0.01, log-rank test).

Reference

1. Halpin SJ, Ford AC. Prevalence of symptoms meeting criteria for irritable bowel syndrome in inflammatory bowel disease: systematic review and meta-analysis. Am J Gastroenterol. 2012; 107:1474–1482. PMID: 22929759.

2. Fukuba N, Ishihara S, Tada Y, et al. Prevalence of irritable bowel syndrome-like symptoms in ulcerative colitis patients with clinical and endoscopic evidence of remission: prospective multicenter study. Scand J Gastroenterol. 2014; 49:674–680. PMID: 24646420.

3. Rachmilewitz D. Coated mesalazine (5-aminosalicylic acid) versus sulphasalazine in the treatment of active ulcerative colitis: a randomised trial. BMJ. 1989; 298:82–86. PMID: 2563951.

4. Matts SG. The value of rectal biopsy in the diagnosis of ulcerative colitis. Q J Med. 1961; 30:393–407. PMID: 14471445.

5. Ishihara S, Tada Y, Fukuba N, et al. Pathogenesis of irritable bowel syndrome: review regarding associated infection and immune activation. Digestion. 2013; 87:204–211. PMID: 23712295.

6. Keohane J, O'Mahony C, O'Mahony L, O'Mahony S, Quigley EM, Shanahan F. Irritable bowel syndrome-type symptoms in patients with inflammatory bowel disease: a real association or reflection of occult inflammation? Am J Gastroenterol. 2010; 105:1788–1794. PMID: 20389294.